Dr. John Robert Leibach, MD

Dr. Leibach practices at Digestive Disease Associates - Primary Care - Gainesville (W Newberry Rd) in Gainesville, Florida.

Dr. Leibach's NPI, 1104841840, was assigned on July 13, 2006. Dr. Leibach graduated from Ohio State College of Medicine in 1972. Dr. Leibach holds Florida license ME0023160.

Dr. Leibach's primary practice is Digestive Disease Associates - Primary Care - Gainesville (W Newberry Rd), at 6400 W Newberry Rd Suite 308 Suite 308, Gainesville, FL 32605-6604. The practice phone is (352) 331-8902. The NPI Registry lists Dr. Leibach's practice address as 6500 W Newberry Rd, Gainesville, FL 32605.

Dr. Leibach's primary practice is Digestive Disease Associates - Primary Care - Gainesville (W Newberry Rd) in Gainesville, Florida. The medical group on file is Digestive Disease Associates of North Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leibach practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Leibach's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Leibach is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Leibach is licensed in Florida.

CMS data shows 136 Medicare services from Dr. Leibach across 3 procedure codes in 2024, for 95 Medicare patients. Medicare paid $12,402 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Leibach in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leibach's median patient age at 69, with 65% women.

In 2022, Dr. Leibach wrote 65 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $6,455 in total drug cost. In 2021, CMS named 211 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Leibach for performance year 2024, reported as part of a group.

Dmand AI links 5 papers to Dr. Leibach, published from 2020 to 2023. Dr. Leibach's most frequent co-authors are Raghav Bassi, MD, Zeeshan H. Ismail, MD and Afzal Hussian Khan, MD.

CMS Open Payments shows 50 general payments to Dr. Leibach from 15 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 96% of the total. Gilead Sciences, Inc. paid the most, $206.

Dmand AI lists 1 award for Dr. Leibach, most recently CMS Stage 1 EHR in 2013.

Dr. Leibach graduated from Ohio State College of Medicine in 1972.

Dr. Leibach is in network with 4 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.